The Global Vaccines Innovation and Immunology Conference (GVX Immunology 2026) will spotlight the transformative role of innovation ecosystems, startups, and emerging technologies in shaping the future of vaccinology and global immunization strategies.
📅 September 21–23, 2026
📍
London, UK & Online
🌍 Driving the Future of Vaccinology
Innovation and entrepreneurship are accelerating the development of
next-generation vaccines and advanced immunization technologies. Startups and
interdisciplinary collaborations are introducing novel approaches that enhance
vaccine discovery, delivery, scalability, and accessibility.
🧬 Emerging Scientific & Technological Areas
This session highlights advances in:
• Next-Generation Vaccine Platforms
• Universal Vaccines & Pan-Coronavirus Strategies
• mRNA 2.0, saRNA & Programmable Vaccinology
• Synthetic Biology & Gene-Circuit Vaccines
• Nanotechnology & Smart Delivery Systems
• Space Immunology & Vaccines in Extreme Environments
• Biosecurity & Biodefense Technologies
• Investor & Industry Innovation Trends
📊 Innovation & Startup Ecosystems
The conference explores how startups, venture investment, and public–private
partnerships are accelerating vaccine innovation. Emerging companies are
pioneering modular manufacturing, AI-driven vaccine design, and scalable
delivery technologies that strengthen global health preparedness.
🌐 Future Perspectives in Vaccinology
Discussions will also focus on:
• Personalized and precision vaccines
• Climate-resilient immunization strategies
• Scalable and equitable vaccine access
• Sustainable innovation models
• Future pandemic preparedness frameworks
📄 Submit Your Abstract
https://vaccines.miconferences.com/abstract-submission
🌐 Conference Website
https://vaccines.miconferences.com/
#GVX2026
#Vaccines #Innovation #Biotech #Immunology #mRNA #Nanotechnology #GlobalHealth
No comments:
Post a Comment